<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="064731-2018"
            EDITION="2018030">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-066371-001</RECEPTION_ID>
      <DELETION_DATE>20180312</DELETION_DATE>
      <FORM_LG_LIST>FR </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>30</NO_OJ>
         <DATE_PUB>20180213</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 030-064731</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="FR">http://ted.europa.eu/udl?uri=TED:NOTICE:064731-2018:TEXT:FR:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>FR</LG_ORIG>
         <ISO_COUNTRY VALUE="FR"/>
         <IA_URL_GENERAL>http://www.ch-beauvais.fr</IA_URL_GENERAL>
         <IA_URL_ETENDERING>https://www.achatpublic.com/sdm/ent/gen/ent_detail.do?PCSLID=CSL_2018_eSPsJH9rSM</IA_URL_ETENDERING>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="FRE2">Picardie</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="FRE2">Picardie</n2016:CA_CE_NUTS>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180209</DS_DATE_DISPATCH>
         <DT_DATE_FOR_SUBMISSION>20180312 16:00</DT_DATE_FOR_SUBMISSION>
         <AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="3">Contract notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="1">Submission for all lots</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B02</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Фpaнция</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Francie</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Frankrig</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Frankreich</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Γαλλία</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Prantsusmaa</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Ranska</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>France</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Fhrainc, an</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Francuska</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Franciaország</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Francia</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Prancūzija</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Franza</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Frankrijk</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Francja</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>França</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Franţa</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Francúzsko</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Francija</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Frankrike</TI_CY>
            <TI_TOWN>Beauvais</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="FR">Centre hospitalier de Beauvais</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F02_2014 CATEGORY="ORIGINAL" FORM="F02" LG="FR">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Centre hospitalier de Beauvais</OFFICIALNAME>
               <ADDRESS>BP 40319 avenue Léon Blum</ADDRESS>
               <TOWN>Beauvais Cedex</TOWN>
               <POSTAL_CODE>60021</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <PHONE>+33 344112046</PHONE>
               <E_MAIL>gcpharmacie@ch-beauvais.fr</E_MAIL>
               <FAX>+33 344112111</FAX>
               <n2016:NUTS CODE="FRE2"/>
               <URL_GENERAL>http://www.ch-beauvais.fr</URL_GENERAL>
               <URL_BUYER>https://www.achatpublic.com/sdm/ent/gen/index.jsp</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <DOCUMENT_FULL/>
            <URL_DOCUMENT>https://www.achatpublic.com/sdm/ent/gen/ent_detail.do?PCSLID=CSL_2018_eSPsJH9rSM</URL_DOCUMENT>
            <ADDRESS_FURTHER_INFO_IDEM/>
            <URL_PARTICIPATION>https://www.achatpublic.com/sdm/ent/gen/ent_detail.do?PCSLID=CSL_2018_eSPsJH9rSM</URL_PARTICIPATION>
            <CA_TYPE_OTHER>Établissement public de santé</CA_TYPE_OTHER>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Fourniture de spécialités pharmaceutiques AOO — groupement de coopération sanitaire «groupement régional d'achats Multi-Segments» — groupement de commande de fourniture de spécialités pharmaceutiques</P>
            </TITLE>
            <REFERENCE_NUMBER>GC Spécialités pharmaceutiques - GRAM</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Fourniture de spécialités pharmaceutiques pour les Pharmacies à usage intérieur (PUI) des adhérents du groupement de coopération sanitaire «Groupement régional d'achats multi-segments» (GRAM) membres du groupement de commandes.</P>
            </SHORT_DESCR>
            <LOT_DIVISION>
               <LOT_ALL/>
            </LOT_DIVISION>
            <OBJECT_DESCR ITEM="1">
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Alginate de sodium oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Misoprostol oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="3">
               <LOT_NO>3</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Isosorbide dinitrate injectable.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="4">
               <LOT_NO>4</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Ivabradine chlorhydrate.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="5">
               <LOT_NO>5</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Bosentan oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="6">
               <LOT_NO>6</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Bosentan oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="7">
               <LOT_NO>7</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Tolvaptan oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="8">
               <LOT_NO>8</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Acebutolol chlorhydrate flacon pda.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="9">
               <LOT_NO>9</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Lercanidipine chlorhydrate flacon pda.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="10">
               <LOT_NO>10</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Losartan hydrochlorothiazide potassique flacon pda.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="11">
               <LOT_NO>11</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Rosuvastatine oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="12">
               <LOT_NO>12</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Fenofibrate oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="13">
               <LOT_NO>13</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Tadalafil oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="14">
               <LOT_NO>14</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Cloxacilline ou oxacilline injectable.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="15">
               <LOT_NO>15</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Daptomycine injectable.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="16">
               <LOT_NO>16</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Entecavir oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="17">
               <LOT_NO>17</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Tenofovir oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="18">
               <LOT_NO>18</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Emtricitabine+tenofovir oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="19">
               <LOT_NO>19</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Lamivudine-abacavir oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="20">
               <LOT_NO>20</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Bendamustine injectable.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="21">
               <LOT_NO>21</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Acide zoledronique injectable.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="22">
               <LOT_NO>22</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Tramadol/paracetamol flacon pda.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="23">
               <LOT_NO>23</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Rasagiline oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="24">
               <LOT_NO>24</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Diazepam oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="25">
               <LOT_NO>25</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Citalopram bromhydrate flacon pda.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="26">
               <LOT_NO>26</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Ivermectine oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="27">
               <LOT_NO>27</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Théophylline à liberation prolongee oral.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="28">
               <LOT_NO>28</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Cetirizine dichlorhydrate flacon P.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="29">
               <LOT_NO>29</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="FRE2"/>
               <SHORT_DESCR>
                  <P>Colistine 1mui injectable.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DURATION TYPE="MONTH">14</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <LEFTI/>
         <PROCEDURE>
            <PT_OPEN/>
            <CONTRACT_COVERED_GPA/>
            <DATE_RECEIPT_TENDERS>2018-03-12</DATE_RECEIPT_TENDERS>
            <TIME_RECEIPT_TENDERS>16:00</TIME_RECEIPT_TENDERS>
            <LANGUAGES>
               <LANGUAGE VALUE="FR"/>
            </LANGUAGES>
            <DURATION_TENDER_VALID TYPE="MONTH">10</DURATION_TENDER_VALID>
            <OPENING_CONDITION>
               <DATE_OPENING_TENDERS>2018-03-13</DATE_OPENING_TENDERS>
               <TIME_OPENING_TENDERS>09:00</TIME_OPENING_TENDERS>
            </OPENING_CONDITION>
         </PROCEDURE>
         <COMPLEMENTARY_INFO>
            <NO_RECURRENT_PROCUREMENT/>
            <INFO_ADD>
               <P>La procédure est conclue sans quantités minimums et maximums. Les offres doivent comporter les pièces énumérées à l'article 4 du Règlement de consultation nº 18/18. La date limite de réception des questions est fixée au 2.3.18(16;00). La date limite de réponse à ces questions, par le Pouvoir adjudicateur, est fixée au 7.3.18(16:00). Les questions et réponses anonymisées sont transmises via la plateforme achatpublic.com à toutes les sociétés ayant retiré un dossier. Des spécimens sont à envoyer avant la date limite de réception des offres. Les critères de jugement des offres sont détaillés à l'article 9 du Règlement de consultation nº 18/18. Le marché débute à compter de la notification et est conclu jusqu'au 30.6.19.</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Tribunal administratif</OFFICIALNAME>
               <ADDRESS>14 rue Lemerchier</ADDRESS>
               <TOWN>Amiens</TOWN>
               <POSTAL_CODE>80011</POSTAL_CODE>
               <COUNTRY VALUE="FR"/>
               <PHONE>+33 322336170</PHONE>
               <E_MAIL>greffe.ta.amiens@juradm.fr</E_MAIL>
               <FAX>+33 322336171</FAX>
               <URL>http://amiens.tribunal-administratif.fr/</URL>
            </ADDRESS_REVIEW_BODY>
            <REVIEW_PROCEDURE>
               <P>— recours en référé précontractuel, avant la signature du marché, </P>
               <P>— recours pour excès de pouvoir avec ou sans référé suspension, dans un délai de 2 mois à compter de la publication de la notification de la décision du Pouvoir adjudicateur, </P>
               <P>— recours en référé contractuel, dans un délai de 31 jours à compter de la publication de l'avis d'attribution, </P>
               <P>— recours en plein contentieux, par tout candidat évincé, dans un délai de 2 mois à compter de la publication de l'avis d'attribution.</P>
            </REVIEW_PROCEDURE>
            <DATE_DISPATCH_NOTICE>2018-02-09</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F02_2014>
   </FORM_SECTION>
</TED_EXPORT>
